Drugs / RDD1609
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03757403 | May → Nov 2020 | — | RDD Pharma Ltd | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RDD1609 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03757403 ↗ |
| Route | Topical | “RDD1609 to be applied on the perianal area BID” NCT03757403 ↗ |